KIR3DL1 and acute lymphoblastic leukemia: - KIR B/x donor genotype is not associated with relapse protection for ALL patients- Total donor centromeric gene content was the best predictor of success with Cen-B/homozygosity being associated with decrease In relapse and improved OS